MIP Diagnostics Staff Headshots-14.jpg



Since 2000, Jim has managed ChimaeraBio, a specialist life sciences investment fund which he founded with Karen Reid. He has also been involved with a number of Scotland’s more successful life science companies, including Haptogen (acquired by Wyeth), Qnostics (acquired by BBI plc) and D3 Technologies (acquired by Renishaw plc). Jim was also Chairman at Lumora upon its very successful exit in 2015.